金朝陽(00878.HK)終止出售禮頓道物業並達成和解 料錄收入3.64億元
金朝陽(00878.HK)公布,有關向獨立第三方徐意出售位於香港禮頓道、希雲道之希雲大廈物業全部權益連相關貸款的交易,由於買方未有按照補充協議協定向賣方支付進一步按金,雙方於昨日(13日)同意以友好方式解決有關事宜。
據此,雙方同意賣方沒收買方在簽署買賣協議時支付之初始按金3.2億元;買方在簽署和解協議時,須向集團支付不可退還之和解金為數3,200萬元;雙方同意終止買賣協議,而買賣協議將停止生效。
公司估計,集團將錄得終止出售事項收入約3.64億元,擬用作一般營運資金。公司並無即時計劃出售目標集團。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.